Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-14

Clinical Trial Update: Feasibility Study of At-Home EEG Monitoring for Hypersomnia [NA]

View source ↗

Summary

A feasibility study on at-home EEG monitoring for hypersomnia and narcolepsy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Hypersomnia, Narcolepsy | NA | Status: WITHDRAWN